共 12 条
[1]
Synthesis and structure–activity relationship of 5-substituent-2(1 H )-pyridone derivatives as anti-fibrosis agents[J] Jun Chen;Miao-Miao Lu;Bin Liu;Zhuo Chen;Qian-Bin Li;Li-Jian Tao;Gao-Yun Hu Bioorganic & Medicinal Chemistry Letters 2012,
[2]
Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors[J] Hirdesh Kumar;Anup Shah;M. Sobhia Journal of Molecular Modeling 2012,
[3]
Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis[J] Ble; Alessandro;Mosca; Marta;Di Loreto; Giorgio;Guglielmotti; Angelo;Biondi; Giuseppe;Bombardieri; Stefano;Remuzzi; Giuseppe;Ruggenenti; Piero EN 2011,
[4]
NADPH oxidase inhibitors: a patent review[J] Jung-Ae Kim;Ganesh Prasad Neupane;Eung Seok Lee;Byeong-Seon Jeong;Byung Chul Park;Pritam Thapa Expert Opinion on Therapeutic Patents 2011,
[5]
NADPH Oxidase Inhibitors: New Antihypertensive Agents?[J] Holly C Williams;Kathy K Griendling Journal of Cardiovascular Pharmacology 2007,
[6]
Inflammatory Cells in Renal Injury and Repair[J] David Ferenbach;David C. Kluth;Jeremy Hughes Seminars in Nephrology 2007,
[7]
Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro[J] European Journal of Pharmaceutical Sciences 2006,
[8]
Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics[J] S Misawa;S Kuwabara;K Kanai;N Tamura;M Nakata;S Sawai;K Yagui;T Hattori Neurology 2006,
[9]
Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: A significant role of specific binding by serum albumin in the improved potency and stability[J] Masuo Kurono;Akihito Fujii;Makoto Murata;Buichi Fujitani;Toshiyuki Negoro Biochemical Pharmacology 2005,
[10]
Recent studies on lonidamine; the lead compound of the antispermatogenic indazol-carboxylic acids[J] Maria Teresa Gatto;Beatrice Tita;Marco Artico;Luciano Saso Contraception 2002,